The U.S. Food and Drug Administration (FDA) has issued a status update for an abbreviated new drug application (ANDA) identified as ANDA083060.
The application concerns an oral tablet product named Isoniazid, 100 mg strength, manufactured by PERRIGO. The product is listed with a marketing status of “Discontinued” and is not designated as a reference drug or reference standard.
Cập nhật pháp chế30 thg 8, 2026•1 phút đọc
FDA Discontinues Isoniazid Tablet (ANDA083060)
FDA lists the oral Isoniazid 100 mg tablet from sponsor PERRIGO (ANDA083060) as discontinued, with no reference drug status.
Tổng hợp bởi đội ngũ PharmaCountry · Nguồn: FDA.gov
Đánh giá
(0)
(0)
(0)
(0)
(0)
Bài viết khác
Xem tất cả bài viếtNghiên cứu & Báo cáo
Global Finished Dosage Manufacturing Landscape 2026
5 thg 10, 2026
Cập nhật pháp chếKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
28 thg 9, 2026
Phân tíchPharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
28 thg 9, 2026
Để lại đánh giá